Sp583
AUTOPHAGY AS A WAY TO IDENTIFY INTESTINAL STEM CELL POPULATIONS
Date
May 7, 2023
Explore related products in the following collection:
Society: AGA
This session will feature speakers who will examine at a sub-single cell level the mechanisms through which organelles shape stem cell biology and cellular plasticity. The session will focus on the role of mitochondria and autophagy in stem cells and how these regulate plasticity.
This session will feature speakers who will examine at a sub-single cell level the mechanisms through which organelles shape stem cell biology and cellular plasticity. The session will focus on the role of mitochondria and autophagy in stem cells and how these regulate plasticity.
Presenter
The Children's Hospital of Philadelphia
Tracks
Related Products
A PHASE 2, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL OF PRA023 AS INDUCTION THERAPY IN PATIENTS WITH MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS: ARTEMIS-UC, COHORT 1
Switching from originator to biosimilar infliximab (IFX) is effective and safe. However, data on multiple switching are scarce. The Edinburgh IBD unit has undertaken three switch programmes: (1) Remicade to CT-P13 (2016), (2) CT-P13 to SB2 (2020), and (3) SB2 to CT-P13 (2021)…
HABITUAL MEAT INTAKE IS ASSOCIATED WITH INCREASED RISK OF DISEASE FLARE IN ULCERATIVE COLITIS: INITIAL RESULTS FROM THE PREDICCT STUDY
Switching from originator to biosimilar infliximab (IFX) is effective and safe. However, data on multiple switching are scarce. The Edinburgh IBD unit has undertaken three switch programmes: (1) Remicade to CT-P13 (2016), (2) CT-P13 to SB2 (2020), and (3) SB2 to CT-P13 (2021)…
ENCAPSULATED MICROBIOTA TRANSPLANT THERAPY IMPROVES PARTIAL MAYO SCORES IN ULCERATIVE COLITIS AND INDUCES RAPID ENGRAFTMENT COMPARED TO PLACEBO CONTROL
Switching from originator to biosimilar infliximab (IFX) is effective and safe. However, data on multiple switching are scarce. The Edinburgh IBD unit has undertaken three switch programmes: (1) Remicade to CT-P13 (2016), (2) CT-P13 to SB2 (2020), and (3) SB2 to CT-P13 (2021)…
AGA Pediatric Organoid Models of GI Disorders
This session will provide the latest developmental research in human-derived organoids…
